Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgens can both increase and decrease hair growth in different parts of the body.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Androgens prevent hair growth by changing Wnt signals in cells.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in certain receptors can cause diseases and offer new treatment options.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Acne is an important sign of androgen excess disorders in women.

Finasteride may improve prostate cancer treatment outcomes.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

No clear link between androgen receptor variation and hair loss, but more research needed.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Certain Dibenzo derivatives may help treat prostate cancer.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.